โ† All Pharmacy Flashcard Decks

Compounding Flashcards

7 cards from real Pharmacy practice questions. Tap to flip, then mark Knew It or Still Learning โ€” missed cards come back until you master them.

Read the first 7 Compounding flashcards as text
  1. A compounder needs to prepare 200 mL of a 2% w/v solution from a 10% w/v stock solution. How many mL of stock solution are needed?

    Answer: 40 mL

    Using C1V1 = C2V2: (10%)(V1) = (2%)(200 mL), so V1 = 40 mL.

  2. According to USP , Category 1 CSPs (compounded sterile preparations) with no antimicrobial preservative stored at room temperature have a BUD of:

    Answer: 24 hours

    USP (2023) assigns a 24-hour BUD at controlled room temperature for Category 1 CSPs without antimicrobial preservatives.

  3. Which type of water is required for preparing compounded sterile preparations (CSPs)?

    Answer: Sterile Water for Injection (WFI)

    Sterile Water for Injection (WFI) meets USP standards for sterility, pyrogen limits, and ionic purity required for CSPs.

  4. When compounding a capsule, what excipient is commonly added as a glidant to improve powder flow?

    Answer: Colloidal silicon dioxide (Cab-O-Sil)

    Colloidal silicon dioxide functions as a glidant by reducing interparticulate friction and improving powder flow in capsule filling.

  5. A pharmacy must conduct media-fill testing when performing sterile compounding. The primary purpose is to:

    Answer: Verify the aseptic technique of the compounder

    Media-fill testing uses a growth medium in place of the drug to simulate the compounding process and verify that the compounder's aseptic technique does not introduce contamination.

  6. Which packaging material is preferred for light-sensitive compounded preparations?

    Answer: Amber glass or amber plastic containers

    Amber glass or plastic protects photosensitive preparations by blocking UV and visible light wavelengths that cause degradation.

  7. According to USP , which category of hazardous drugs requires full containment controls (C-PEC + C-SEC) even for non-sterile compounding?

    Answer: NIOSH Table 1 antineoplastic drugs

    NIOSH Table 1 antineoplastic (chemotherapy) agents require the highest level of containment engineering controls under USP .